THE BALANCEhttps://thebalance.clinic/resources/addiction/drugs/hallucinogen-persisting-perception-disorder-symptoms-and-assessment/
THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Hallucinogen Persisting Perception Disorder: Symptoms and Assessment

Persistent visual changes after psychedelic use deserve careful assessment, not assumptions. Learn how clinicians distinguish HPPD from acute effects and other conditions, recognize urgent warning signs, and discuss care despite limited treatment evidence.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Trails behind moving objects, persistent afterimages, or static-like vision after psychedelic use can be unsettling. Hallucinogen persisting perception disorder, or HPPD, is one possible explanation, but other conditions can look similar. This guide explains symptoms, assessment, urgent warning signs, and care choices. It supports a clinical conversation rather than providing a diagnosis or medication plan.

What Is Hallucinogen Persisting Perception Disorder?

Hallucinogen persisting perception disorder, usually called HPPD, involves perceptual disturbances that continue or recur after the acute effects of a substance have ended. The disturbances are often visual. A clinical diagnosis also requires significant distress or interference with daily life and consideration of other explanations. Not every unusual visual experience after psychedelic use is HPPD. [1], [3]

The word flashback can be misleading because people use it for anything from a momentary visual change to an emotionally intense memory. HPPD assessment focuses on what you perceive, when it happens, and how it affects you, rather than the label alone. Research sometimes separates brief episodes from persistent symptoms, but proposed HPPD type 1 and type 2 categories are not established DSM diagnostic subtypes. [1]

A prospective study published in 2025 distinguished HPPD-like visual effects from distressing clinical illness. Its self-selected sample and short follow-up do not establish population risk. This distinction matters: a symptom deserves attention without automatically meaning that you have a lasting disorder. [2]

Recognizing Persistent Perceptual Symptoms

People may describe trails behind moving objects, unusually persistent afterimages, halos, intensified colors, geometric patterns, or objects appearing larger or smaller than they are. An afterimage that remains after an object is no longer present is sometimes called palinopsia. Describe the experience in ordinary language; you do not need to learn medical terminology before seeking help. [3]

Clinical reports also describe visual snow, meaning a grainy or static-like appearance across vision, sensitivity to light, floating spots, and difficulty seeing at night. These features overlap with other conditions and are not individually diagnostic of HPPD. [1]

For an appointment, explain what the symptom prevents you from doing. Does text become difficult to follow? Do lights interfere with evening travel? Are you avoiding work because you fear another episode? These examples give the clinician more useful information than simply rating the visuals as mild or severe.

Do not deliberately provoke symptoms by staring at bright lights or repeatedly testing your vision. Bring naturally occurring observations instead, and mention any abrupt change separately.

Acute Drug Effects, Persistent Symptoms, and Exposure History

Visual changes during intoxication are different from symptoms that remain or return after intoxication ends. HPPD can involve continuous symptoms or intermittent episodes. Published accounts describe different intervals between substance exposure and symptom onset, so timing needs careful reconstruction rather than an assumed cutoff. [3], [6]

LSD is frequently discussed in the literature, but reported associations extend beyond LSD. They include psilocybin, ayahuasca, MDMA, and cannabis-related exposures. Reports involving several substances make it difficult to identify one cause or compare risks reliably. Evidence does not support a precise personal risk estimate for each product. [3]

Write down what you believe you took, approximately when, whether substances were combined, and whether the product's contents were uncertain. Include use before and after symptoms began, not only the experience you suspect caused them.

You do not need to identify as addicted to request help with a persistent adverse effect. If controlling use is also difficult, our drug-related resources can help you prepare that separate conversation.

What a Clinical Assessment Should Cover

Start with a healthcare professional who can review the visual symptoms and arrange appropriate examination or referral. Depending on the findings, assessment may involve ophthalmology, neurology, psychiatry, or more than one specialty. There is no single scan or laboratory result that establishes HPPD. Eye and neurological investigations were often normal in a small specialist case series, but normal findings do not make symptoms imaginary. [1]

Prepare a brief timeline covering your vision before substance use, the suspected exposure, the first symptoms, subsequent changes, and periods without symptoms. Note whether the disturbance affects one eye or both, whether it is constant or episodic, and whether headaches, altered awareness, or other physical symptoms accompany it.

Bring a complete medication list, including prescriptions, over-the-counter products, supplements, and nonprescribed substances. Previous eye examinations and relevant medical records may prevent unnecessary repetition.

Ask what the clinician considers most likely, which alternatives remain possible, and what each proposed test would clarify. Before leaving, agree who will coordinate referrals, when results will be reviewed, and what changes require earlier contact. An uncertain initial diagnosis should still come with a clear next step.

Conditions That Can Resemble HPPD

Persistent visual symptoms should not automatically be attributed to past drug use. Migraine aura, visual snow syndrome, focal seizures, and eye disease can produce overlapping experiences. The pattern, duration, exposure history, and accompanying findings help clinicians distinguish them. Migraine-related visual symptoms can occur without a headache. [4]

Visual snow syndrome may resemble HPPD, particularly when grainy vision occurs alongside afterimages or light sensitivity. A temporal relationship with substance use is important when considering HPPD, but resemblance alone does not establish the cause. [4]

HPPD also should not be used as a catch-all explanation for paranoia, disorganized thinking, or loss of contact with reality. Assessment needs to distinguish perceptual disturbances from psychotic illness and identify whether conditions coexist. [3], [4]

Tell the clinician if symptoms existed before the suspected exposure or have recently changed character. Avoid withholding an earlier symptom because it seems to weaken your explanation. The purpose of assessment is to find appropriate care, not to prove a preferred diagnosis.

When Visual Changes or Distress Need Urgent Help

Seek immediate medical assessment for sudden partial or complete vision loss, a curtain or shadow across vision, sudden double vision, or a painful red eye with blurred vision. Sudden new blind spots or distorted vision also need urgent evaluation. Do not assume these are familiar HPPD symptoms, even if you already have that diagnosis. [8]

In the United States, call 911 or go to the nearest emergency department for a medical emergency or immediate danger. If you are experiencing suicidal thoughts or a mental health or substance use crisis, call or text 988. A planned consultation or international treatment journey should never delay urgent local care. [9]

As a practical safety precaution, do not drive, operate machinery, or undertake hazardous work when visual disturbances prevent reliable perception. Ask your clinician how to assess a safe return rather than testing yourself in traffic.

THE BALANCE is not an emergency service. Persistent but stable symptoms belong in a planned assessment pathway; sudden deterioration needs a fresh safety decision.

Anxiety, Depression, and Other Co-Occurring Concerns

HPPD assessment should include emotional health, not just vision. A 2026 retrospective health-record study found associations with anxiety, depressive episodes, headache syndromes, and several other conditions. Such associations do not show that one condition caused another, and recorded diagnoses are not equivalent to independently confirming every case. [5]

Explain whether you are frightened by the visual changes, avoiding everyday activities, struggling to sleep, or feeling hopeless. These concerns need their own assessment rather than being dismissed as an inevitable reaction. Conversely, identifying anxiety does not prove that anxiety explains all visual symptoms.

If ongoing substance use is part of the picture, ask for a coordinated plan that addresses both the perceptual symptoms and the reasons for continued use. Our European private drug addiction treatment guide provides context for planned adult care in Europe, not a substitute for US emergency or specialist services.

You can also use the mental health resource collection to prepare questions about broader concerns. Bring those questions to the same coordinating clinician where possible.

Treatment Choices and Medication Evidence

There is no well-established medication treatment pathway supported by randomized controlled HPPD trials. A 2025 systematic review found a small evidence base dominated by case reports, case series, and observational studies. Reports of improvement cannot reliably separate medication effects from natural recovery, treatment of co-occurring conditions, or publication bias. [6]

Clinicians have tried medicines including lamotrigine, clonidine, and clonazepam, but the evidence does not establish a preferred treatment for everyone. Some reports describe worsening with risperidone. This is a reason for careful prescribing and monitoring, not a blanket instruction to avoid antipsychotic treatment when another condition requires it. [6]

Benzodiazepines require particular caution because they can cause misuse, physical dependence, and potentially dangerous withdrawal. Do not obtain them informally or abruptly stop an existing prescription. Our guide to benzodiazepine withdrawal and clinical support explains why medication changes need professional oversight. [7]

Before a medication trial, ask which problem it targets, what improvement would count as worthwhile, what adverse effects to watch for, and when the decision will be reviewed. Also ask whether its use for HPPD is off-label. Avoid changing several treatments independently, which makes later assessment harder.

Daily Support and the Role of Psychological Care

Supportive care may include education, avoiding further recreational substance exposure, attention to sleep and daily routines, and psychological support. These approaches are practice-based rather than proven methods for eliminating HPPD. They should complement appropriate medical assessment, not replace it. [6]

Cognitive behavioral therapy may help address fear, avoidance, and the disruption surrounding symptoms. Its role should be explained honestly: HPPD-specific evidence is limited, and therapy is not proof that the visual experiences are invented or simply caused by negative thinking. The linked page explains the broader therapy approach rather than a dedicated HPPD protocol. [6]

Choose practical goals with your clinician or therapist. Examples include returning to manageable reading periods, maintaining appointments, or resuming a valued activity safely. Consider temporary changes to lighting, workload, or travel arrangements according to your actual difficulties.

If keeping a record, make it brief enough to be useful. Note meaningful changes and functioning rather than checking vision throughout the day. Ask the team how often they want updates and what information would change the plan. Be cautious about products or online programs promising a guaranteed reset or cure.

Family Support, Care Settings, and Recovery

Family members can help by listening without blame, offering transportation, and helping prepare appointment questions when invited. Ask what support the person wants rather than repeatedly asking whether the visuals have disappeared. Avoid calling symptoms punishment for drug use or insisting that reassurance alone should end them.

With permission, agree how relatives can share concerns and which clinician to contact. Supporters should not be expected to diagnose new symptoms, manage medication changes, or replace professional monitoring.

Use our guide to choosing a level of care to structure questions about outpatient, residential, or hospital needs. HPPD alone should not determine a treatment setting. Ask prospective providers whether they can assess this presentation, coordinate necessary specialists, and explain what requires treatment elsewhere. Do not assume THE BALANCE offers every specialist intervention.

Published cases include both improvement and continuing symptoms, so recovery cannot be promised on a fixed timetable. [1] Agree follow-up around concrete goals: safer functioning, less distress, appropriate treatment of co-occurring conditions, and review of the visual symptoms. Before any transition between providers, confirm the next appointment, responsible clinician, medication arrangements, and route for urgent help.

Questions

Frequently Asked Questions

Can HPPD happen after using a psychedelic only once?

Cases have been reported after a single exposure, although reports cannot establish the likelihood for an individual. Repeated use is not required before persistent symptoms deserve assessment. Tell the clinician about the exposure and symptom timeline without assuming that the connection proves HPPD. [3]

Is HPPD the same as being permanently intoxicated?

No. HPPD describes persistent or recurring perceptual symptoms after the acute drug effects have ended. Calling it a permanent trip can obscure the distinction and increase fear. A clinician still needs to exclude ongoing intoxication, medication effects, and other explanations. [1], [6]

Does visual snow automatically mean I have HPPD?

No. Visual snow can occur without a drug-related trigger. Assessment considers when it began, accompanying symptoms, substance exposure, and eye or neurological findings. Similar-looking symptoms can have different causes, so an online image comparison cannot establish the diagnosis. [4]

Can HPPD occur after ayahuasca?

Published literature has associated ayahuasca with HPPD, but evidence is limited and does not provide a reliable individual risk estimate. A ceremonial setting or natural origin does not rule out persistent adverse effects. Describe all substances taken during and around the experience. [3]

Should I stop my psychiatric medication if visual symptoms worsen?

Contact the prescriber rather than stopping independently. The clinician should assess the timing, benefits, adverse effects, and underlying condition. Abruptly stopping a benzodiazepine can cause dangerous withdrawal, including seizures. New severe symptoms may need urgent assessment rather than a routine medication appointment. [7], [8]

How long does HPPD last?

There is no dependable individual timeline. Published cases include improvement, full recovery, and continuing symptoms, but small selected samples cannot predict your outcome. Follow-up should assess daily functioning and distress as well as visual changes, without promising a cure date. [1], [6]

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01Ford et al. Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature. Frontiers in Neurology, 2022.View source
02Zhou et al. Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use. PNAS Nexus, 2025.View source
03Martinotti et al. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences, 2018.View source
View all 9 sourcesShow fewer sources
04Visual Phenomena Associated With Migraine and Their Differential Diagnosis. Deutsches Ärzteblatt International, 2021.View source
05Characterising the clinical associations of hallucinogen persisting perception disorder: a retrospective cohort study. Translational Psychiatry, 2026.View source
06Neven and Blom. Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review. Harvard Review of Psychiatry, 2025.View source
07FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class.View source
08MedlinePlus Medical Encyclopedia: Vision problems.View source
09SAMHSA: Crisis Help: Suicide, Mental Health, Drug, and Alcohol Issues.View source
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care